Integral DiagnosticsITGDF -52.38%75 EV-to-FCF is 51.95 as of Jun. 29, 2026, which is 52% above its 10-year median of 34.16. GuruFocus rates ITGDF with a GF Score™ of 75/100 and a GF Value™ of $1.39. The stock has 9 warning signs investors should review. Among 97 Medical Diagnostics & Research companies, Integral Diagnostics ranks worse than 75.26% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Integral Diagnostics's Enterprise Value is $908.1 Mil.
Integral Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $17.5 Mil. Therefore, Integral Diagnostics's EV-to-FCF for today is 51.95.
The historical rank and industry rank for Integral Diagnostics's EV-to-FCF or its related term are showing as below:
ITGDF'
s EV-to-FCF Range Over the Past 10 Years
Min: 17.03 Med: 34.16 Max: 102.21
Current: 49.34
During the past 10 years, the highest EV-to-FCF of Integral Diagnostics was 102.21. The lowest was 17.03. And the median was 34.16.
ITGDF's EV-to-FCF is ranked worse than 75.26% of 97
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.6
vs ITGDF: 49.34
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Integral Diagnostics (OTCPK:ITGDF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Integral Diagnostics's PE Ratio (TTM) for today is calculated as:
Integral Diagnostics's share price for today is $1.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.027.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Integral Diagnostics EV-to-FCF Related Terms
Integral Diagnostics EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Integral Diagnostics's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Integral Diagnostics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integral Diagnostics EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Integral Diagnostics's EV-to-FCF falls into.
Integral Diagnostics's current Enterprise Value is $908.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Integral Diagnostics's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $17.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integral Diagnostics (ITGDF) has a EV-to-FCF of 51.95 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Integral Diagnostics and its competitors. This is 52% above median its historical median of 34.16. Over the past decade, Integral Diagnostics' EV-to-FCF has ranged from 17.03 to 102.21. According to the industry distribution chart, Integral Diagnostics ranks #73 out of 97 companies in the Medical Diagnostics & Research industry, placing it in the top 75.3%.
Is Integral Diagnostics' EV-to-FCF too high?
Integral Diagnostics' current EV-to-FCF of 51.95 is 52% above median its 10-year median of 34.16. Over the past 10 years, this metric has ranged from a low of 17.03 to a high of 102.21. The Medical Diagnostics & Research industry median EV-to-FCF is 22.60. Integral Diagnostics' value of 51.95 is 129.9% above this industry median. Based on the distribution chart, Integral Diagnostics ranks #73 out of 97 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Integral Diagnostics has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integral Diagnostics ranks #73 out of 97 companies for EV-to-FCF. This places Integral Diagnostics in the lower half of its industry. The industry median EV-to-FCF is 22.60. Integral Diagnostics' value of 51.95 is 129.9% above this benchmark. Historically, Integral Diagnostics' own EV-to-FCF has ranged from 17.03 to 102.21 over the past decade. While the company's 10-year median is 34.16 vs. the industry median of 22.60, Integral Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.60, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integral Diagnostics's current EV-to-FCF of 51.95 is 129.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Integral Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integral Diagnostics's current EV-to-FCF is 51.95, which is 52% above median its own 10-year median of 34.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Integral Diagnostics (ITGDF) has a current EV-to-FCF of 51.95. The stock's GF Value™ is $1.39, compared to a current price of $1.00 — trading 28.1% below its estimated fair value. The current EV-to-FCF is 51.95, which is 52% above median its 10-year median of 34.16 and 129.9% above the Medical Diagnostics & Research industry median of 22.60. Integral Diagnostics' overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Integral Diagnostics (ITGDF), the current EV-to-FCF is 51.95 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integral Diagnostics (ITGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued.
The current stock price of $1.00 is trading 28.1% below its estimated GF Value™ of $1.39.
Key valuation signals for ITGDF:
EV-to-FCF: 51.95 (52% above median its 10-year median of 34.16)
GF Value™: $1.39 vs. price of $1.00 (28.1% below fair value)
Industry Position: 129.9% above the Medical Diagnostics & Research median (#73 of 97)
No single metric tells the full story. See the ITGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
75GF Score
Get the complete analysis for ITGDF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ITGDF has been successfully added to your 
